within Pharmacolibrary.Drugs.ATC.P;

model P02CB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 2.5 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 300 / 1000000,
    adminCount     = 1,
    Vd             = 0.0022,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.006333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Diethylcarbamazine is an anthelmintic agent used primarily for the treatment of filarial infections such as lymphatic filariasis, loiasis, and tropical pulmonary eosinophilia. It is an approved medication, still used in many countries for control and elimination of filarial diseases.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from studies in healthy adult volunteers, typically both male and female, after oral administration.</p><h4>References</h4><ol><li><p>Bala, V, et al., &amp; Murry, DJ (2021). Population Pharmacokinetics of Diethylcarbamazine in Patients with Lymphatic Filariasis and Healthy Individuals. <i>Antimicrobial agents and chemotherapy</i> 65(10) e0031721–None. DOI:<a href=&quot;https://doi.org/10.1128/AAC.00317-21&quot;>10.1128/AAC.00317-21</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34310218/&quot;>https://pubmed.ncbi.nlm.nih.gov/34310218</a></p></li><li><p>Bolla, S, et al., &amp; Jasti, BR (2002). Pharmacokinetics of diethylcarbamazine after single oral dose at two different times of day in human subjects. <i>Journal of clinical pharmacology</i> 42(3) 327–331. DOI:<a href=&quot;https://doi.org/10.1177/00912700222011247&quot;>10.1177/00912700222011247</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11865970/&quot;>https://pubmed.ncbi.nlm.nih.gov/11865970</a></p></li><li><p>Chhonker, YS, et al., &amp; Murry, DJ (2023). Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis. <i>PLoS neglected tropical diseases</i> 17(8) e0011567–None. DOI:<a href=&quot;https://doi.org/10.1371/journal.pntd.0011567&quot;>10.1371/journal.pntd.0011567</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37616301/&quot;>https://pubmed.ncbi.nlm.nih.gov/37616301</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end P02CB02;
